The Federal Government has announced a ban on the importation of several pharmaceutical products, including widely used medicines such as paracetamol and metronidazole, as part of a revised import prohibition policy.
The directive, issued by the Federal Ministry of Finance and dated April 1, 2026, lists 17 categories of items now restricted from entering the country through any port, with a strong focus on boosting local production.
Among the affected drugs are paracetamol (tablets and syrups), metronidazole, cotrimoxazole, chloroquine, aspirin, folic acid, multivitamins, and certain topical antibiotics. Under the new policy, these medicines are expected to be produced locally, increasing pressure on Nigeria’s pharmaceutical industry to meet demand.
Beyond healthcare, the ban extends to other sectors. Imports of frozen poultry, beef, pork, and eggs remain restricted, while refined vegetable oils packaged for retail sale are also prohibited. Additionally, items such as detergents, soaps, ballpoint pens, cement, and selected steel products are included in the list.
The policy is aimed at reducing reliance on imports, conserving foreign exchange, and encouraging domestic industries. However, stakeholders have raised concerns about the potential impact on healthcare delivery, particularly if local manufacturers are unable to scale production quickly.
Experts warn that in the short term, the restrictions could lead to supply shortages and increased prices for essential medicines, affecting accessibility for many Nigerians.
The Nigeria Customs Service has been tasked with enforcing the directive, with non-compliant imports subject to seizure and penalties.
While the government maintains that the policy will strengthen local capacity in the long run, its immediate effects are expected to be felt across pharmacies, markets, and households nationwide.
